JPMorgan Healthcare Leaders ETF (NASDAQ:JDOC) Short Interest Update

JPMorgan Healthcare Leaders ETF (NASDAQ:JDOC) was the target of a large drop in short interest during the month of January. As of January 31st, there was short interest totalling 100 shares, a drop of 50.0% from the January 15th total of 200 shares. Based on an average daily volume of 500 shares, the short-interest ratio is currently 0.2 days.

JPMorgan Healthcare Leaders ETF Price Performance

NASDAQ:JDOC opened at $53.83 on Friday. The firm has a market capitalization of $8.07 million, a price-to-earnings ratio of 27.37 and a beta of 0.61. JPMorgan Healthcare Leaders ETF has a 1 year low of $50.54 and a 1 year high of $63.49. The business has a 50 day simple moving average of $52.97 and a 200-day simple moving average of $57.46.

JPMorgan Healthcare Leaders ETF Cuts Dividend

The business also recently disclosed a dividend, which was paid on Friday, December 27th. Stockholders of record on Tuesday, December 24th were paid a $0.3276 dividend. The ex-dividend date of this dividend was Tuesday, December 24th.

Institutional Investors Weigh In On JPMorgan Healthcare Leaders ETF

An institutional investor recently bought a new position in JPMorgan Healthcare Leaders ETF stock. Krilogy Financial LLC acquired a new stake in shares of JPMorgan Healthcare Leaders ETF (NASDAQ:JDOC) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 10,212 shares of the company’s stock, valued at approximately $517,000. Krilogy Financial LLC owned 6.81% of JPMorgan Healthcare Leaders ETF as of its most recent SEC filing.

JPMorgan Healthcare Leaders ETF Company Profile

The JPMorgan Healthcare Leaders ETF Healthcare Leaders ETF (JDOC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies located around the globe.The adviser seeks to provide long-term capital appreciation.